Pavel Krsek Selected Research

Pavel Krsek Research Topics

Disease

22	Epilepsy (Aura) 01/2022 - 08/2007
17	Tuberous Sclerosis (Bourneville's Disease) 01/2022 - 11/2013
13	Seizures (Absence Seizure) 01/2022 - 12/2000
8	Drug Resistant Epilepsy 01/2022 - 11/2002
6	Focal Cortical Dysplasia 12/2021 - 01/2010
5	Autism Spectrum Disorder 01/2022 - 07/2018
5	Intellectual Disability (Idiocy) 01/2022 - 01/2017
4	Inborn Genetic Diseases (Disease, Hereditary) 01/2022 - 11/2016
4	Partial Epilepsies (Epilepsy, Partial) 01/2021 - 03/2016
3	Inflammation (Inflammations) 09/2020 - 01/2016
3	Autistic Disorder (Autism) 01/2020 - 01/2017
2	Cognitive Dysfunction 10/2020 - 11/2019
2	Neuroinflammatory Diseases 09/2020 - 01/2019
2	Encephalitis (Encephalitis, Rasmussen) 09/2020 - 07/2017
2	Hydrocephalus (Hydrocephaly) 01/2020 - 12/2010
2	Temporal Lobe Epilepsy 02/2009 - 08/2007
1	Human Influenza (Influenza) 01/2022
1	Cysts 12/2021
1	Myoclonic Epilepsies (Myoclonic Encephalopathy) 01/2021
1	Autoimmune Diseases of the Nervous System 01/2021
1	Progressive Myoclonic Epilepsies (Progressive Myoclonic Epilepsy) 01/2021
1	Infantile Spasms (West Syndrome) 01/2021
1	Movement Disorders (Movement Disorder) 09/2020
1	Neurocutaneous Syndromes (Phakomatoses) 01/2020
1	Astrocytoma (Pilocytic Astrocytoma) 01/2020
1	Leukocytosis (Pleocytosis) 01/2019
1	Rhabdomyoma 07/2018
1	Hippocampal Sclerosis 10/2017
1	Nervous System Diseases (Neurological Disorders) 11/2016
1	Diabetes Mellitus 06/2016
1	Hamartoma 01/2016
1	Gliosis 01/2016
1	Disease Progression 11/2015
1	Facial Pain (Myofacial Pain) 01/2015
1	Status Epilepticus (Complex Partial Status Epilepticus) 04/2012
1	Frontal Lobe Epilepsy (Epilepsy, Supplementary Motor) 03/2012
1	Stroke (Strokes) 12/2010
1	Asphyxia (Suffocation) 12/2010
1	Neurologic Manifestations (Neurological Manifestations) 12/2010
1	Brain Injuries (Brain Injury) 12/2010
1	Malformations of Cortical Development 12/2010
1	Hemorrhage 12/2010
1	Sturge-Weber Syndrome (Sturge-Kalischer-Weber Syndrome) 02/2010
1	Infantile Epileptic-Dyskinetic Encephalopathy 11/2002
1	Brain Diseases (Brain Disorder) 11/2002

Drug/Important Bio-Agent (IBA)

19	trans-sodium crocetinate (crocetin)IBA 01/2022 - 11/2013
9	Pharmaceutical PreparationsIBA 01/2021 - 11/2002
4	Mechanistic Target of Rapamycin Complex 1IBA 01/2020 - 01/2016
3	Biomarkers (Surrogate Marker)IBA 01/2022 - 01/2019
3	Anticonvulsants (Antiepileptic Drugs)IBA 01/2021 - 11/2002
3	Vigabatrin FDA Link 01/2021 - 01/2020
3	Proteins (Proteins, Gene)FDA Link 10/2020 - 01/2019
3	TOR Serine-Threonine KinasesIBA 01/2016 - 11/2015
2	Methotrexate (Mexate)FDA LinkGeneric 09/2020 - 07/2017
2	Alemtuzumab (Campath)FDA Link 09/2020 - 07/2017
2	Protons (Proton)IBA 02/2009 - 08/2007
1	Cell Adhesion MoleculesIBA 01/2022
1	Pneumococcal Vaccines (Pneumococcal Polysaccharide Vaccine)IBA 01/2022
1	Everolimus FDA Link 01/2021
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 09/2020
1	Azathioprine (Imuran)FDA LinkGeneric 09/2020
1	Natalizumab (Tysabri)FDA Link 09/2020
1	IronIBA 09/2020
1	Serum AlbuminIBA 01/2019
1	Interleukin-6 (Interleukin 6)IBA 01/2019
1	CytokinesIBA 01/2019
1	Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA 01/2019
1	Oligoclonal BandsIBA 01/2019
1	AMPA Receptors (AMPA Receptor)IBA 11/2016
1	Glucose (Dextrose)FDA LinkGeneric 06/2016
1	ElectrolytesIBA 06/2016
1	AntibodiesIBA 06/2016
1	SteroidsIBA 06/2016
1	ChromatinIBA 11/2015
1	MTOR InhibitorsIBA 11/2015
1	Biological ProductsIBA 01/2015
1	Methylphenidate (Ritalin)FDA LinkGeneric 04/2012
1	mitomycin C-dextranIBA 12/2010
1	Calbindin 2IBA 01/2010
1	Chloral HydrateIBA 11/2002
1	Kainic Acid (Kainate)IBA 12/2000

Therapy/Procedure

5	Therapeutics 01/2021 - 11/2002
2	Electrodes (Electrode) 11/2021 - 03/2007
1	Treatment Delay 01/2021
1	Immunotherapy 09/2020
1	Ketogenic Diet 11/2015
1	Hemispherectomy 02/2010